secwatch / observer

Recent Earnings 8-K events

Recent 8-Ks about earnings releases, operating results, guidance, and financial updates.

50 recent filings JSON RSS

August 12, 2026, 12:32 PM ET GBR New Concept Energy, Inc. negative materiality 0.30

New Concept Energy Q2 2026 net loss widens to $66K on higher G&A

JSON Markdown SEC source
August 12, 2026, 11:02 AM ET NGS NATURAL GAS SERVICES GROUP INC neutral materiality 0.50

NGS reports Q2 2026 earnings; Flatrock Acquisition referenced as accretive

JSON Markdown SEC source
August 12, 2026, 10:59 AM ET U. S. Premium Beef, LLC negative materiality 0.50

USPB Q2 FY2026 net loss $5.2M vs $4.7M year ago; YTD loss narrows to $12.2M

JSON Markdown SEC source
August 12, 2026, 9:30 AM ET MNPR Monopar Therapeutics positive materiality 0.80

Monopar Q2 net loss $5.3M; initiates rolling NDA for ALXN1840

JSON Markdown SEC source
August 12, 2026, 9:18 AM ET NEON Neonode Inc. negative materiality 0.60

Neonode Q2 revenue down 20% to $0.5M; loss widens to $0.13/share

JSON Markdown SEC source
August 12, 2026, 9:08 AM ET CAPS Capstone Holding Corp. positive materiality 0.70

Capstone Q2 revenue up 67% to $21.5M; Stone Business EBITDA positive as guided

JSON Markdown SEC source
August 12, 2026, 9:05 AM ET SPRB SPRUCE BIOSCIENCES, INC. positive materiality 0.80

Spruce Biosciences Q2 2026: cash $96.3M, TA-ERT BLA on track for Q4, $5.5M investment

JSON Markdown SEC source
August 12, 2026, 8:45 AM ET DYAI DYADIC INTERNATIONAL INC negative materiality 0.60

Dyadic Q2 2026 revenue flat at $961K; net loss $2.12M, cash down to $4.79M

JSON Markdown SEC source
August 12, 2026, 8:45 AM ET LVO LiveOne, Inc. positive materiality 0.75

LiveOne Q1 FY2027 revenue $19.4M, adjusted EBITDA $4.3M vs -$1.8M YoY; PodcastOne record $16.1M

JSON Markdown SEC source
August 12, 2026, 8:45 AM ET PODC PodcastOne, Inc. positive materiality 0.75

PodcastOne reports record Q1 FY2027 revenue of $16.1M, Adjusted EBITDA up 172% to $1.6M

JSON Markdown SEC source
August 12, 2026, 8:35 AM ET APRE Aprea Therapeutics, Inc. positive materiality 0.70

Aprea Q2 2026: net loss $3.6M, cash $41.2M, APR-1051 enrollment accelerating

JSON Markdown SEC source
August 12, 2026, 8:30 AM ET FLYX FLYEXCLUSIVE INC. neutral materiality 0.50

flyExclusive issues Q2 2026 earnings review; specific financial figures not in provided text

JSON Markdown SEC source
August 12, 2026, 8:12 AM ET IPSC Century Therapeutics, Inc. positive materiality 0.65

Century Therapeutics Q2 2026: Net loss $34.6M, cash $197.2M, CNTY-813 IND on track for 4Q26

JSON Markdown SEC source
August 12, 2026, 8:09 AM ET MSGE Madison Square Garden Entertainment Corp. positive materiality 0.75

MSG Entertainment FY26 revenue up 13% to $1.06B; AOI up 18% to $262.2M

JSON Markdown SEC source
August 12, 2026, 8:06 AM ET AVLN Avalyn Pharma Inc. neutral materiality 0.60

Avalyn reports Q2 net loss $28.9M; completes MIST enrollment with 398 patients

JSON Markdown SEC source
August 12, 2026, 8:05 AM ET EAT BRINKER INTERNATIONAL, INC positive materiality 0.80

Brinker Q4 FY26 EPS $2.99, comp sales +5%, FY27 EPS guide $12.60-13.40

JSON Markdown SEC source
August 12, 2026, 8:04 AM ET UNCY Unicycive Therapeutics, Inc. neutral materiality 0.60

Unicycive Q2 net loss narrows to $1.7M; FDA assigns OLC facility inspection

JSON Markdown SEC source
August 12, 2026, 7:35 AM ET XLO Xilio Therapeutics, Inc. positive materiality 0.70

Xilio reports Q2 2026 results; FDA clears IND for XTX501 bispecific PD-1/masked IL-2

JSON Markdown SEC source
August 12, 2026, 7:33 AM ET ALT Altimmune, Inc. positive materiality 0.70

Altimmune Q2 net loss $22.8M; initiates Phase 3 MASH trial, positive AUD data

JSON Markdown SEC source
August 12, 2026, 7:31 AM ET ABUS Arbutus Biopharma Corp positive materiality 0.80

Arbutus Q2 net loss $5.1M; receives $178M Moderna payment, plans $230M buyback

JSON Markdown SEC source
August 12, 2026, 7:31 AM ET LOCL Local Bounti Corporation/DE positive materiality 0.65

Local Bounti Q2 revenue up 14% to $13.9M; net loss narrows to $19.8M

JSON Markdown SEC source
August 12, 2026, 7:28 AM ET MIST Milestone Pharmaceuticals Inc. neutral materiality 0.65

Milestone Q2 2026 net loss $28.6M; CARDAMYST coverage jumps to ~50% of commercial lives

JSON Markdown SEC source
August 12, 2026, 7:26 AM ET AADX Applied Aerospace & Defense, Inc. positive materiality 0.85

Applied Aerospace Q2 revenue $167.3M (+47.4% YoY); net loss $154M on IPO costs; backlog $1.13B

JSON Markdown SEC source
August 12, 2026, 7:15 AM ET STRO SUTRO BIOPHARMA, INC. neutral materiality 0.80

Sutro Q2 revenue drops to $9.8M from $63.7M; STRO-004 shows early responses

JSON Markdown SEC source
August 12, 2026, 7:15 AM ET TCRX TScan Therapeutics, Inc. neutral materiality 0.65

TScan Q2 net loss narrows to $30.4M; first patient dosed in Phase 3 ALLOHA-2 trial

JSON Markdown SEC source
August 12, 2026, 7:10 AM ET CYPH CYPHERPUNK TECHNOLOGIES INC. positive materiality 0.80

Cypherpunk Q2 net income $39.4M on ZEC gain; FDA aligns on Phase 3 for sirexatamab

JSON Markdown SEC source
August 12, 2026, 7:05 AM ET FRVO Fervo Energy Co neutral materiality 0.70

Fervo Q2 net loss $55.9M; raises 2030 target to 1.1 GW after $2.2B IPO

JSON Markdown SEC source
August 12, 2026, 7:03 AM ET HUMA Humacyte, Inc. positive materiality 0.80

Humacyte Q2: Symvess sales up, net loss $36.8M; V012 Phase 3 hits primary endpoint

JSON Markdown SEC source
August 12, 2026, 7:02 AM ET LXEO Lexeo Therapeutics, Inc. positive materiality 0.75

Lexeo Q2 net loss $25.9M; initiates LX2006 pivotal trial, gains RMAT for LX2020

JSON Markdown SEC source
August 12, 2026, 7:02 AM ET ABOS Acumen Pharmaceuticals, Inc. neutral materiality 0.50

Acumen Q2 2026 net loss $32.7M, cash $110.2M; ALTITUDE-AD topline due late 2026

JSON Markdown SEC source
August 12, 2026, 7:02 AM ET OCTV Octave Intelligence plc negative materiality 0.75

Octave Q2 revenue falls 4% YoY to $398M; $2.1B non-cash impairments drive $1,971M net loss

JSON Markdown SEC source
August 12, 2026, 7:01 AM ET TRMB TRIMBLE INC. positive materiality 0.85

Trimble Q2 revenue $972M (+11% YoY); raises FY26 guidance; $1B buyback

JSON Markdown SEC source
August 12, 2026, 7:00 AM ET SPMC Sound Point Meridian Capital, Inc. neutral materiality 0.65

SPMC reports Q1 FY27 NAV $9.88, NII $0.24/sh; declares $0.13 monthly distribution

JSON Markdown SEC source
August 12, 2026, 7:00 AM ET PFGC Performance Food Group Co positive materiality 0.80

PFG Q4 FY26 EPS $1.03, revenue $18.0B; FY26 diluted EPS $2.29; FY27 guidance issued

JSON Markdown SEC source
August 12, 2026, 6:59 AM ET PLX Protalix BioTherapeutics, Inc. positive materiality 0.60

Protalix Q2 2026: YTD revenue $53.6M, net income $22.1M; Elfabrio patent extended to 2035

JSON Markdown SEC source
August 12, 2026, 6:51 AM ET KTB Kontoor Brands, Inc. positive materiality 0.85

Kontoor Q2 revenue +19% to $584M, raises FY26 EPS outlook, plans $400M ASR

JSON Markdown SEC source
August 12, 2026, 6:50 AM ET TE T1 Energy Inc. neutral materiality 0.80

T1 Energy Q2 2026: $250M net sales, $10.7M adj EBITDA; Clearway 641MW deal, $135M IP buy

JSON Markdown SEC source
August 12, 2026, 6:45 AM ET LQDA Liquidia Corp positive materiality 0.90

Liquidia posts Q2 2026 net income of $74.7M; YUTREPIA sales surge to $170.4M

JSON Markdown SEC source
August 12, 2026, 6:30 AM ET TECH BIO-TECHNE Corp neutral materiality 0.75

Bio-Techne Q4 revenue $321M, adjusted EPS $0.52; dividend $0.08; Merck deal on track

JSON Markdown SEC source
August 12, 2026, 6:30 AM ET ANNX Annexon, Inc. positive materiality 0.75

Annexon Q2 net loss $55.3M; BLA for tanruprubart on track for Q4 2026

JSON Markdown SEC source
August 12, 2026, 6:09 AM ET AMCR Amcor plc positive materiality 0.85

Amcor Q4 adj. EPS $1.23 (+23%), FY adj. EPS $4.02 (+13%); dividend raised to 65c

JSON Markdown SEC source
August 12, 2026, 6:05 AM ET BETA BETA Technologies, Inc. neutral materiality 0.75

BETA Q2 revenue up 146% to $14.7M; net loss widens to $148.8M

JSON Markdown SEC source
August 12, 2026, 6:03 AM ET EYE National Vision Holdings, Inc. positive materiality 0.75

National Vision Q2 2026: revenue +2.5%, adj. EPS $0.25, raises FY adj. operating income guidance

JSON Markdown SEC source
August 12, 2026, 6:03 AM ET NYC American Strategic Investment Co. positive materiality 0.70

American Strategic Investment Q2 2026 net loss narrows to $8.3M; NYSE compliance restored

JSON Markdown SEC source
August 11, 2026, 7:38 PM ET DIOD DIODES INC /DEL/ neutral materiality 0.60

Diodes Q2 2026 earnings call held; specific results not disclosed in exhibit

JSON Markdown SEC source
August 11, 2026, 7:07 PM ET AVR Anteris Technologies Global Corp. neutral materiality 0.70

Anteris six-month 2026: revenue $1.503M (+28% YoY), net loss widens to $52.1M

JSON Markdown SEC source
August 11, 2026, 6:25 PM ET BRN BARNWELL INDUSTRIES INC positive materiality 0.60

Barnwell Q3 FY26: net loss narrows to $440K; positive Adjusted EBITDA $425K

JSON Markdown SEC source
August 11, 2026, 5:29 PM ET INUV Inuvo, Inc. negative materiality 0.80

Inuvo Q2 2026: revenue down 67% to $7.5M, net loss $4.0M; CFO Ruiz to retire

JSON Markdown SEC source
August 11, 2026, 5:26 PM ET RDVT Red Violet, Inc. positive materiality 0.80

Red Violet Q2 2026: revenue up 23% to $26.7M; net income $5.0M (+85%)

JSON Markdown SEC source
August 11, 2026, 5:19 PM ET ELOX Eloxx Pharmaceuticals, Inc. neutral materiality 0.75

Eloxx Q2 2026 net loss $4.5M; cash $62M; exaluren Phase 2b to start Q3 2026

JSON Markdown SEC source